Surface-modified paclitaxel-loaded nanoparticles as local delivery system for the prevention of vessel restenosis

Yaoxue Xuebao

Volumn 42, Issue 1, 2007, Pages 81-86

  Mei, Lin ^a   Song, Cun Xian ^a   Jin, Xu ^a   Che, Yong Zhe ^b   Jin, Zhe ^c   Sun, Hong Fan ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b NANKAI UNIVERSITY   (China)

^c TIANJIN FIRST CENTRAL HOSPITAL   (China)

Author keywords

Angioplasty; Didodecylmethylammonium bromide; Nanoparticle; Paclitaxel; Restenosis

Indexed keywords

ANTINEOPLASTIC AGENT; LACTIC ACID; NANOPARTICLE; PACLITAXEL; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BALLOON DILATATION; CAROTID ARTERY INJURY; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FEMALE; HYPERPLASIA; INJURY; INTIMA; MALE; NANOTECHNOLOGY; PARTICLE SIZE; PATHOLOGY; RABBIT;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BALLOON DILATATION; CAROTID ARTERY INJURIES; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; FEMALE; HYPERPLASIA; LACTIC ACID; MALE; NANOPARTICLES; NANOTECHNOLOGY; PACLITAXEL; PARTICLE SIZE; POLYGLYCOLIC ACID; RABBITS; TUNICA INTIMA;

EID: 33847719892     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Uwatoku T, Shimokawa H, Abe K, et al. Application of nanoparticle technology for the prevention of restenosis after balloon injury in rats [J]. Circ Res, 2003, 92:62-69.
2. Westedt U, Barbu-Tudoran L, Schaper AK, et al. Deposition of nanoparticles in the arterial vessel by porous balloon catheters: localization by confocal laser scanning microscopy and transmission electron microscopy [J]. AAPS Pharm Sci, 2002, 4:1-6.
3. Labhasetwar V, Song C, Levy RJ. Nanoparticle drug delivery system for restenosis [J]. Adv Drug Deliver Rev, 1997,24:63-85.
4. Song C, Labhasetwar V, Cui X, et al. Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: results with an acute dog model [J]. J Control Release, 1998,54:201-211.
5. Guzman LA, Labhasetwar V, Song C, et al. Local infusion of biodegradable polymeric nanoparticles: a novel approach for prolonged drug delivery after balloon angioplasty [J]. Circulation, 1996,94:1441-1448.
6. Sollott SJ, Cheng L, Pauly RR, et al. Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat [J]. J Clin Invest, 1995, 95: 1869-1876.
7. Kim DW, Kwon JS, Kim YJ, et al. Novel oral formulation of paclitaxel inhibits neointimal hyperplasia in a rat carotid artery injury model [J]. Circulation, 2004, 109:1558-1563.
8. He JT, Tao XM, Mo W, et al. Preparation and characterization a staphylokinase of PLGA microspheres containing variant (K35R) [J]. Acta Pharm Sin, 2006,41:12-18.
9. Huh KM, Lee SC, Cho YW, et al. Hydrotropic polymer micelle system for delivery of paclitaxel [J]. J Control Release, 2005,101:59-68.
10. Rupert LAM, Hoekstra D, Engberts BFN. Fusogenic behavior of didodecyldimethylammonium bromide bilayer vesicles [J]. J Am Chem Soc, 1985, 107:2628-2631.
11. You J, Kamihira M, Iijima S. Surfactant-mediated gene transfer for animal cells [J]. Cytotechnology, 1997,25: 45-52.
12. Panyam J, Dali MM, Sahoo SK, et al. Polymer degradation and in vitro release of a model protein from poly(D, L-lactide-co-glycolide) nano- and microparticles [J]. J Control Release, 2003,92:173-187.
13. Moses JW, Kipshidze N, Leon MB. Perspectives of drug-eluting stents: the next revolution [J]. Am J Cardiovasc Drugs, 2002,2:165-172.